Back to search

National and Kapodistrian University of Athens

Σεξουαλικές διαταραχές ασθενών με σκλήρυνση κατά πλάκας: συνδυασμός ουρολογικών δοκιμασιών

Abstract

dc:description

Introduction.Multiple sclerosis (MS) is a chronic inflammatory disease in which sexualdisorders (erectile dysfunction, ejaculation disorders, anorgasmia etc.) arefrequently encountered in both sexes and are difficult to treat.Οbjective.In this paper, we attempt to record the SEP profile in MS patients and correlatethe findings with the healthy population. Furthermore, we correlate the severity ofurinary and sexual symptoms of the MS population with the SEP findings and theresponse to the treatment. Finally we would assess in double randomizedplacebo controlled study, efficacy and safety profile of Yohimbine for thetreatment of the ejaculatory disorders in male patients. Materials and MethodsTwenty nine patients, who fulfilled the criteria of Poser et al for diagnosis of MS,were enrolled in this study (patients group) and, at the same time, 10 healthysubjects were also evaluated (control group). A detailed urologic, neurologic andsexual questionnaire was delivered to each one patient and, in cases of a malepatient, to the healthy female sexual partner as well. Neurophysiologic studieswere performed to the subjects of both study groups included the tibial nerveSEP (TNSEP) and the pudendal nerve (penile and clitoris) evoked potentialsrecording. Male patients were also subjected to erectile function evaluation, and a tri- mix ofvasoactive agents was used for the treatment of erectile dysfunction at home.Patients with delayed or absent ejaculations are randomized into two groups, Aand B. In group A, yohimbine 15mg p.os. is given, while in patients of group Bplacebo is used.ResultsThe mean age for the control group was 40,7±8,74 years and for patients41,3±10.28 respectively while p=0,867 and the height was for controls175.1±11.02 cm and 174.6±8.32 cm for the patients respectively, while p=0.889.Statistically significant differences for latency times between patients andcontrols with respect to the average response times presented in inter N20 and P40L. More specifically, latency time N10pud in patients with intermittent courseof the disease presents an average response time increased by 1.81 comparedwith patients with progressive disease course, while the P40 amplitude inpatients with intermittent course disease presents median range reduced by 0.45in comparison with patients with progressive disease. From all the latency timesstatistically significant (p value<0.05) latency time N50 tib L is positivelycorrelated with mobility (correlation coefficient=0.59, P value=0.022). Statisticallysignificant negative correlation was found between sexual disorders of men andpotential amplitude P40 R (correlation coefficient=0.81, P value = 0.002).Regarding intracavernosal injections treatment with vasoactive substances (trimix)which is performed at home, 8 patients increased their sexual intercourses ≥3 times a week, 7 patients ≥ 2 -fold and 9 patients more than once, respectively.Regarding the bulbocavernous muscle reflex was positive in 13 normal men,delayed in 7 and absent in 4. Finally eight men from Yohimbine (n = 15) and twofrom placebo (n = 9) group respectively showed positive results regarding theejaculatory function.Conclusion: The sexual disorders in MS patient is one of the main problemsburdening further mental health and depression they are suffering because of thedisease . The patients whose disease follows an intermittent course tend to havemajor abnormalities in neurophysiological tests compared with those who have aprogressive degenerative course and these abnormalities are strictly related torespective sexual disorders. Intracavernosal injection of vasoactive substances isthe most effective treatment of erectile dysfunction in these patients. Yohimbineshowed a clear superiority in comparison to placebo in amelioration of ejaculatory disorders in male patients with MS.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mertziotis, Nikolaos
  • Μερτζιώτης, Νικόλαος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42538

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mertziotis, Nikolaos; Μερτζιώτης, Νικόλαος. Σεξουαλικές διαταραχές ασθενών με σκλήρυνση κατά πλάκας: συνδυασμός ουρολογικών δοκιμασιών. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42538